Novartis Investigative Site

Sondrio, SO 23100

0 studies enrolling now · 2 studies all time

What they study most

HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer — Completed
• Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer — Stopped early